4.5 Review

Obesity in the US: what is the best role for primary care?

期刊

BMJ-BRITISH MEDICAL JOURNAL
卷 350, 期 -, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmj.g7846

关键词

-

资金

  1. Nestle Healthcare Nutrition
  2. Vivus
  3. Novo Nordisk
  4. Eisai pharmaceutical

向作者/读者索取更多资源

The increasing prevalence of obesity together with projected increases in diabetes over the next 20-30 years will put a substantial strain on the finances and resources of the US healthcare system. The best opportunity for broad scale treatment of obesity may lie in the primary care setting. This review assesses the evidence on the efficacy of treatment for obesity delivered in primary care in the United States. It summarizes an earlier systematic review, recent obesity treatment guidelines, and subsequent US based trials with a minimum follow-up of six months in which at least one member of a primary care team helped deliver comprehensive behavioral obesity treatment to adults with overweight or obesity. Overall, the evidence suggests that obesity treatment delivered in primary care has limited effectiveness. Questions remain about the optimal role of the primary care provider in the treatment of obesity and the prevention of weight gain, as well as potential systems approaches to the treatment of obesity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据